Center for Biologic Basis of Oral/Systemic Diseases (CB*

$1,451,533P20FY2009RRNIH

University Of Kentucky, Lexington KY

Investigators

Linked publications, trials & patents

Paper 33826149 Paper 33593992 Paper 32769481 Paper 32207317 Paper 32075482 Paper 31863783 Paper 31860742 Paper 31364280 Paper 30936023 Paper 30885927 Paper 30629741 Paper 30555774 Paper 30470434 Paper 30277577 Paper 30178698 Paper 29476652 Paper 29132178 Paper 29066255 Paper 28542026 Paper 28514232 Paper 27925695 Paper 27739035 Paper 27549083 Paper 27501491 Paper 27486459 Paper 27431617 Paper 27273425 Paper 26884502 Paper 26817032 Paper 26673774 Paper 26407063 Paper 26347856 Paper 26033565 Paper 25956706 Paper 25905537 Paper 25818051 Paper 25708960 Paper 24975876 Paper 24879575 Paper 24733985 Paper 24630161 Paper 24283398 Paper 23894113 Paper 23574466 Paper 23524547 Paper 23270529 Paper 23116507 Paper 23021916 Paper 22926406 Paper 22769406 Paper 22705569 Paper 22373349 Paper 22289394 Paper 22126530 Paper 22084302 Paper 21967939 Paper 21967938 Paper 21810622 Paper 21703074 Paper 21480939 Paper 21471327 Paper 21459369 Paper 21420664 Paper 21261488 Paper 21175023 Paper 21073452 Paper 20880053 Paper 20831736 Paper 20798974 Paper 20711846 Paper 20610663 Paper 20348544 Paper 20331801 Paper 20233650 Paper 20139337 Paper 19702954 Paper 19627526 Paper 19602109 Paper 19563296 Paper 19563294 Paper 19556448 Paper 19527448 Paper 19416455 Paper 19380752 Paper 19364391 Paper 19117124 Paper 19051251 Paper 18948273 Paper 18805716 Paper 18305431 Paper 17976852 Paper 17908844 Paper 17435146 Paper 17210663 Paper 16913241 Paper 16549076 Trial NCT00632957

Abstract

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. To implement an intervention trial to effectively improve oral health in the GDM women with "at-risk" pregnancies and lower the risk of adverse pregnancy outcomes.

View original record on NIH RePORTER →